hybridization analysis revealed that the human SKI gene is deleted in our patient, some genes in 1p36, including SKI proto-oncogene, may be involved in muscle hypotonia and delayed motor development in this syndrome.
Introduction
Chromosome 1p36 deletion syndrome is a recently recognized, relatively common contiguous gene deletion syndrome, i.e., a genomic disorder. The prevalence of the syndrome is estimated to be 1/10,000 newborns (Shapira et al. 1997) . It is associated with muscle hypotonia and moderate to severe developmental delay, growth retardation, microcephaly, and craniofacial dysmorphism with a large anterior fontanelle, prominent forehead, deep-set eyes, flat nasal bridge and midface hypoplasia, ear asymmetry, and a pointed chin (Shapira et al. 1997; Slavotinek et al. 1999) . Minor cardiac malformations, dilated cardiomyopathy, epileptic seizures, and ventricular dilatation are additional findings. Muscle hypotonia and delayed motor development are almost constant features of the syndrome. Genes distal to 1p36 are deleted and may be associated with various manifestations of the syndrome. The extent of the deletion is variable with the shortest region of overlap for deletion; however, the causative genes for developmental abnormalities have not been identified (Wu et al. 1999) . Colmenares et al. (2002) found that SKI proto-oncogene may contribute to some of the phenotypes common in 1p36 deletion syndrome, particularly to facial clefting.
We report a patient with 1p36 deletion syndrome whose muscle pathology showed congenital fiber type disproportion (CFTD). CFTD myopathy is characterized by type 1 fibers smaller than type 2 fibers (Brooke and Engel 1969) . The molecular basis of CFTD is unknown. Chromosome 1p36 deletion and CFTD seen together in a patient may Abstract Chromosome 1p36 deletion syndrome is characterized by hypotonia, moderate to severe developmental and growth retardation, and characteristic craniofacial dysmorphism. Muscle hypotonia and delayed motor development are almost constant features of the syndrome. We report a 4-year-old Japanese girl with 1p36 deletion syndrome whose muscle pathology showed congenital fiber type disproportion (CFTD) myopathy. This is the first case report of 1p36 deletion associated with CFTD. This association may indicate that one of the CFTD loci is located at 1p36. Ski proto-oncogene Ϫ/Ϫ mice have phenotypes that resemble some of the features observed in patients with 1p36 deletion syndrome. Because fluorescent in situ indicate that one of the genes located at 1pter-36 is associated with the pathogenesis of CFTD.
Clinical report
The patient was a 4-year-old Japanese girl born to nonconsanguineous healthy parents who were both 32 years old. Birth weight of the patient was 2890 g at 41 weeks of gestation. Apgar scores were 9 at 1 min and 10 at 5 min, respectively. At 9 days of age, she was transferred to a hospital because of abnormal ocular movement with vertical nystagmus. She was difficult to feed. Right congenital hip dislocation was noted, which later necessitated surgical treatment. Conventional G-banded chromosome analysis showed a normal 46,XX karyotype. At 7 months of age, she was introduced to our hospital because of dilated cardiomyopathy. She had dysmorphic features that included microcephalus, prominent forehead, widely patent anterior fontanelle, hypertelorism, deep-set eyes, midface hypoplasia, flat nasal bridge, nasal deformation with minute cleft lip in the right side, low-set ears, down slanting oral corners, pointed chin, and generalized hypotonia. Deep tendon reflex was diminished. At 10 months of age, she developed repeated nonepileptic apneic episodes that sometimes required resuscitation. Home oxygen therapy was effective to relieve apnea. She started to crawl at 18 months, and sat at 21 months. Serum creatine kinase (CK) levels were slightly or mildly elevated (max 526 U/l; normal range, 30-150 U/l). Laboratory tests for various metabolic disorders were unremarkable. Electroencephalography showed no epileptic findings. Magnetic resonance imaging of the brain showed unremarkable change. At two years of age, electromyography (EMG) showed a myogenic change. Muscle biopsy of the left biceps muscle was done to evaluate the pathogenesis of hypotonia (Fig. 1) . The diagnosis of CFTD was made; however, it was not enough to explain her dysmorphic features and severe developmental delay. At 4 years of age, her weight was 13.8 kg (Ϫ0.9 SD), length 95.3 cm (Ϫ1.1 SD) and head circumference 49.0 cm (Ϫ0.9 SD). Dilated cardiomyopathy was still remarkable (Fig. 2) . Her hypotonia continued and she could stand with support. She could speak no meaningful words. Her clinical manifestations were consistent with 1p36 deletion syndrome. Subsequent analysis by fluorescent in situ hybridization (FISH) using a distal 1p probe (D1Z2) demonstrated a deletion at 1p36.3-pter. Her karyotype was thus 46,XX.ish del(1)(p36.3) (D1Z2-). FISH analysis with a SKI-containing bacterial artificial chromosome (BAC) clone (CTD-2245C8) confirmed that SKI was also deleted (Fig. 3) . In further studies, the extent of the deletion was estimated to be smaller than 3 Mb (Table 1) . Karyotypes of her parents were normal.
Discussion
Clinical features observed in the girl included severe developmental delay, generalized hypotonia, and dysmorphic Table 1 . Deleted and nondeleted regions in the patient as detected by FISH using probes at the distal end of 1p
features, all of which are typical for 1p36 deletion syndrome. The association of 1p36 deletion with CFTD has hitherto been reported. The genetic basis of CFTD remains unclear. Additionally, type 1 fiber atrophy is a common finding in childhood neuromuscular disorders, especially congenital myopathies (Imoto and Nonaka 2001) . Because both autosomal dominant and recessive types of CFTD have been reported, it is believed to be genetically heterogeneous. Jaffe et al. (1998) reported two siblings affected with congenital progressive severe myopathy transmitted by an autosomal recessive mode. Muscle biopsy revealed fiber type disproportion with no other histological abnormalities, confirming the diagnosis of CFTD. Gerdes et al. (1994) reported a patient with myopathy and CFTD present at birth with arthrogryposis multiplex congenita, dislocation of the hips, and mild scoliosis. In this patient, a balanced chromosomal translocation t(10;17)(p11.2;q25), transmitted by a clinically healthy mother, who nevertheless showed discrete signs of myopathy, was demonstrated. Gerdes et al. (1994) suggested that CFTD in the family may be dominantly inherited with variable expressivity and that either of the translocation breakpoints may harbor a candidate gene region. There are no further studies on the genetic mapping of CFTD. The number of reported pedigrees with CFTD is too small for linkage analysis.
Many genes are deleted in patients with 1p36 deletion syndrome. The neuroblastoma suppressor genes have been mapped to this region (White et al. 1995) . Phenotype/ genotype correlation and refinements of critical regions delineated specific areas for the causative genes (Wu et al. 1999) . For example, hemizygosity of KCNAB2 is a significant risk factor for severe epilepsy (Heilstedt et al. 2001) . Myopathy in our patient may be explained by haploinsufficiency of the putative causative genes or unmasking of certain recessive alleles. So far, several genes at 1p36 are known to be associated with muscle development. Microscopic analysis of the skeletal muscle from Pax7(Ϫ/Ϫ) mice showed complete absence of satellite cells, markedly decreased muscle mass, and reduced fiber caliber (Seale et al. 2000) . The human PAX7 is assigned to 1p36.2-36 (Stapleton et al. 1993 ). Deletion of PAX7 was excluded in our patient by FISH analysis with a BAC clone, RPCI-11 330C5 (data not shown). Human DVL1 is mapped to 1p36.3 and is widely expressed in fetal and adult tissues, including the brain, lung, kidney, skeletal muscle, and heart. DVL1 is deleted in some 1p36 deletion patients (Shapira et al. 1997; Bedell et al. 1996; Pizzuti et al. 1996) . However, Dvl1-deficient mice are viable, fertile, and structurally normal (Lijam et al. 1997 ). Human AGRIN is mapped to 1pter-p36. Agrin is a component of the synaptic basal lamina that induces the clustering (aggregation) of acetylcholine receptors on cultured muscle fibers. Gautam et al. (1996) generated knockout mice deficient for agrin and showed that neuromuscular development was severely disturbed. Homozygous mutant mice died in utero or were stillborn. Gautam et al. (1996) reported that conventional histological analysis failed to detect gross abnormalities in any tissues.
The Ski proto-oncogene has been implicated in the control of cell growth and skeletal muscle differentiation. Sutrave et al. (1990) showed that overexpression of Ski in skeletal muscles of transgenic mice leads to selective hypertrophy of type 2 fast fibers. In particular, type 2B fibers showed remarkable hypertrophy. Berk et al. (1997) disrupted the mouse Ski gene, and Ski(Ϫ/Ϫ) mice showed perinatal lethality, resulting from exencephaly and a dramatic reduction in skeletal muscle mass, consistent with a defect in expansion of a myogenic precursor population. Colmenares et al. (2002) showed that Ski(Ϫ/Ϫ) mice in the C57BL/J background showed midline facial clefting, depressed nasal bridge, eye abnormalities, skeletal muscle defects, and digit abnormalities. The phenotype in these mice resembles some of the features observed in patients with 1p36 deletion syndrome. Colmenares et al. (2002) found that human SKI was deleted in patients with 1p36 deletion syndrome, and suggested that SKI may contribute to some of the phenotypes common in the syndrome. Our patient showed significantly hypotrophic but predominant type 1 fibers and deficiency of type 2B fibers in some fascicles. Gene dosage effect of SKI may explain selective hypertrophy of type 2B fibers in transgenic mice, deficiency of type 2B fibers in our (hemizygous) patient, and dramatic reduction of skeletal muscle mass in Ski(Ϫ/Ϫ) (nullizygous) mice. Although fiber-type specific abnormalities were not described in Ski(ϩ/Ϫ) and (Ϫ/Ϫ) mice, we suspect that the SKI deletion may be related to CFTD in our patient. Some of the other 1p36 deletion patients, especially those with severe hypotonia, may have muscle abnormalities. Because the serum CK level is not always high in such a patient, screening by EMG and confirmation by muscle biopsy are recommended. CFTD patients with mental retardation, dysmorphic features, and multiple anomalies should be investigated for 1p36 deletion.
Our patient and four other patients with 1p36 deletion were reported to have infantile cardiomyopathy (KepplerNoreuil et al. 1995; Slavotinek et al. 1999) . Metabolic disor- Fig. 3 . Fluorescent in situ hybridization using a SKI containing bacterial artificial chromosome (BAC) clone, CTD-2245C8. Arrow indicates deletion of SKI on an abnormal chromosome 1, although SKI signal appears on normal chromosome 1 ders for cardiomyopathy were excluded. A combination of cardiomyopathy and CFTD has been described (Banwell et al. 1999) , whereas cardiac abnormalities were not described in Ski(Ϫ/Ϫ) mice. It remains to be investigated whether cardiomyopathy is a component of 1p36 deletion syndrome or is associated with CFTD.
